Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hatzl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Surgical Oncology|July 17, 2001
Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissectionP Schrenk, M Hatzl-Griesenhofer, A Shamiyeh, et al.
Nuklearmedizin. Nuclear Medicine|January 19, 2002
[The insufficiency fracture of the sacrum. An often unrecognized cause of low back pain: results of bone scanning in a major hospital]M Hatzl-Griesenhofer, R Pichler, H Huber, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 2, 1998
[Clinical application of biopsy of the sentinel lymph node in breast carcinoma]P Schrenk, M Hatzl, R Rieger, et al.
Wiener Klinische Wochenschrift|June 23, 1999
[Primary lymphoma of the thyroid with contralateral recurrence--case report]R Pichler, M Hatzl-Griesenhofer, H Huber, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 22, 2003
Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' diseaseR Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Wiener Klinische Wochenschrift|April 25, 1997
[Hyperthyroidism caused by TSH producing hypophyseal adenoma]R Pichler, M Hatzl, H Huber, et al.
Wiener Klinische Wochenschrift|April 11, 2001
Enterovirus infection--a possible trigger for Graves' disease?R Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Nuklearmedizin. Nuclear Medicine|November 1, 2000
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]R Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Nuklearmedizin. Nuclear Medicine|June 27, 2014
Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignanciesS Woelfl, S Bogner, H Huber, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Surgical Oncology|July 17, 2001
Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissectionP Schrenk, M Hatzl-Griesenhofer, A Shamiyeh, et al.
Nuklearmedizin. Nuclear Medicine|January 19, 2002
[The insufficiency fracture of the sacrum. An often unrecognized cause of low back pain: results of bone scanning in a major hospital]M Hatzl-Griesenhofer, R Pichler, H Huber, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|December 2, 1998
[Clinical application of biopsy of the sentinel lymph node in breast carcinoma]P Schrenk, M Hatzl, R Rieger, et al.
Wiener Klinische Wochenschrift|June 23, 1999
[Primary lymphoma of the thyroid with contralateral recurrence--case report]R Pichler, M Hatzl-Griesenhofer, H Huber, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|August 22, 2003
Soluble tumour necrosis factor-alpha receptor I and interleukin-6 as markers of activity in thyrotoxic Graves' diseaseR Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Wiener Klinische Wochenschrift|April 25, 1997
[Hyperthyroidism caused by TSH producing hypophyseal adenoma]R Pichler, M Hatzl, H Huber, et al.
Wiener Klinische Wochenschrift|April 11, 2001
Enterovirus infection--a possible trigger for Graves' disease?R Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Nuklearmedizin. Nuclear Medicine|November 1, 2000
[Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods]R Pichler, W Maschek, M Hatzl-Griesenhofer, et al.
Nuklearmedizin. Nuclear Medicine|June 27, 2014
Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignanciesS Woelfl, S Bogner, H Huber, et al.
Pageof 1